AtriCure
ATRC
201 hedge funds and large institutions have $1.39B invested in AtriCure in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 58 increasing their positions, 79 reducing their positions, and 34 closing their positions.
308% more call options, than puts
Call options by funds: $824K | Put options by funds: $202K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more capital invested
Capital invested by funds: $1.16B → $1.39B (+$230M)
15% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 34
2% more funds holding
Funds holding: 197 → 201 (+4)
3.52% less ownership
Funds ownership: 104.9% → 101.38% (-3.5%)
27% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 79
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$31.9M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$26M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$9.53M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$6.47M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.1M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$20.9M |
| 3 |
Millennium Management
New York
|
-$14.8M |
| 4 |
BlackRock
New York
|
-$7.64M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$6.01M |
ATRC Hedge Fund Activity: Q3 2024 in Review
201 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2024, worth a combined $1.39B — up 20% from $1.16B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ATRC positions and 34 closed out — a net gain of 5 holders — while 58 added to existing stakes and 79 trimmed.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $31.9M. The largest seller was Fidelity Investments, cutting an estimated $28.1M.
- 201 institutional investors held AtriCure (ATRC) as of Q3 2024, up from 197 in Q2 2024.
- Funds reported $1.39B of AtriCure stock for Q3 2024, up 20% quarter-over-quarter.
- 39 funds opened new AtriCure positions in Q3 2024 and 34 closed out, a net change of +5 holders.
- The largest AtriCure buyer in Q3 2024 was Divisadero Street Capital Management, an estimated $31.9M added.
- The largest AtriCure seller in Q3 2024 was Fidelity Investments, an estimated $28.1M sold.
Based on aggregated 13F filings for Q3 2024.